The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Measles Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
The global Measles Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Measles Vaccine in various end use industries. The expanding demands from the Children and Adults, are propelling Measles Vaccine market. Mumps Measles Rubella Vaccine, Live (MMR-II), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Measles Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Measles Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Measles Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Measles Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Measles Vaccine covered in this report include GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic and Emergent Biosolutions, etc.
The global Measles Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
Global Measles Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Measles Vaccine market, Segment by Type:
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Global Measles Vaccine market, by Application
Children
Adults
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Measles Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Measles Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Measles Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Measles Vaccine in various end use industries. The expanding demands from the Children and Adults, are propelling Measles Vaccine market. Mumps Measles Rubella Vaccine, Live (MMR-II), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Measles Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Measles Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Measles Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Measles Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Measles Vaccine covered in this report include GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic and Emergent Biosolutions, etc.
The global Measles Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
Global Measles Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Measles Vaccine market, Segment by Type:
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Global Measles Vaccine market, by Application
Children
Adults
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Measles Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Measles Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Measles Vaccine Market Overview
1.1 Measles Vaccine Product Overview
1.2 Measles Vaccine Market Segment by Type
1.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Global Measles Vaccine Market Size by Type
1.3.1 Global Measles Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Measles Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Measles Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Measles Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Measles Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Measles Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Measles Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Measles Vaccine Sales Breakdown by Type (2018-2023)
2 Global Measles Vaccine Market Competition by Company
2.1 Global Top Players by Measles Vaccine Sales (2018-2023)
2.2 Global Top Players by Measles Vaccine Revenue (2018-2023)
2.3 Global Top Players by Measles Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Measles Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Measles Vaccine Market Competitive Situation and Trends
2.5.1 Measles Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Measles Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Measles Vaccine Market
2.8 Key Manufacturers Measles Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Measles Vaccine Status and Outlook by Region
3.1 Global Measles Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Measles Vaccine Historic Market Size by Region
3.2.1 Global Measles Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Measles Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Measles Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Measles Vaccine Forecasted Market Size by Region
3.3.1 Global Measles Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Measles Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Measles Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Measles Vaccine by Application
4.1 Measles Vaccine Market Segment by Application
4.1.1 Children
4.1.2 Adults
4.2 Global Measles Vaccine Market Size by Application
4.2.1 Global Measles Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Measles Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Measles Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Measles Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Measles Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Measles Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Measles Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Measles Vaccine Sales Breakdown by Application (2018-2023)
5 North America Measles Vaccine by Country
5.1 North America Measles Vaccine Historic Market Size by Country
5.1.1 North America Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Measles Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Measles Vaccine Sales in Value by Country (2018-2023)
5.2 North America Measles Vaccine Forecasted Market Size by Country
5.2.1 North America Measles Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Measles Vaccine Sales in Value by Country (2024-2029)
6 Europe Measles Vaccine by Country
6.1 Europe Measles Vaccine Historic Market Size by Country
6.1.1 Europe Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Measles Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Measles Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Measles Vaccine Forecasted Market Size by Country
6.2.1 Europe Measles Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Measles Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Measles Vaccine by Region
7.1 Asia-Pacific Measles Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Measles Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Measles Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Measles Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Measles Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Measles Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Measles Vaccine Sales in Value by Region (2024-2029)
8 Latin America Measles Vaccine by Country
8.1 Latin America Measles Vaccine Historic Market Size by Country
8.1.1 Latin America Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Measles Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Measles Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Measles Vaccine Forecasted Market Size by Country
8.2.1 Latin America Measles Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Measles Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Measles Vaccine by Country
9.1 Middle East and Africa Measles Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Measles Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Measles Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Measles Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Measles Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Measles Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Measles Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Measles Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Measles Vaccine Products Offered
10.4.5 Novartis Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Measles Vaccine Products Offered
10.5.5 Pfizer Recent Development
10.6 Serum Institute of India
10.6.1 Serum Institute of India Company Information
10.6.2 Serum Institute of India Introduction and Business Overview
10.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Serum Institute of India Measles Vaccine Products Offered
10.6.5 Serum Institute of India Recent Development
10.7 China National Biotech Group
10.7.1 China National Biotech Group Company Information
10.7.2 China National Biotech Group Introduction and Business Overview
10.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 China National Biotech Group Measles Vaccine Products Offered
10.7.5 China National Biotech Group Recent Development
10.8 Bavarian Nordic
10.8.1 Bavarian Nordic Company Information
10.8.2 Bavarian Nordic Introduction and Business Overview
10.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bavarian Nordic Measles Vaccine Products Offered
10.8.5 Bavarian Nordic Recent Development
10.9 Emergent Biosolutions
10.9.1 Emergent Biosolutions Company Information
10.9.2 Emergent Biosolutions Introduction and Business Overview
10.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Emergent Biosolutions Measles Vaccine Products Offered
10.9.5 Emergent Biosolutions Recent Development
10.10 Medimmune
10.10.1 Medimmune Company Information
10.10.2 Medimmune Introduction and Business Overview
10.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medimmune Measles Vaccine Products Offered
10.10.5 Medimmune Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Company Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Johnson & Johnson Measles Vaccine Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 CSL Limited
10.12.1 CSL Limited Company Information
10.12.2 CSL Limited Introduction and Business Overview
10.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 CSL Limited Measles Vaccine Products Offered
10.12.5 CSL Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Measles Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Measles Vaccine Industrial Chain Analysis
11.4 Measles Vaccine Market Dynamics
11.4.1 Measles Vaccine Industry Trends
11.4.2 Measles Vaccine Market Drivers
11.4.3 Measles Vaccine Market Challenges
11.4.4 Measles Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Measles Vaccine Distributors
12.3 Measles Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
